iosBio
2 known investors
iosBio develops oral, thermostable vaccine candidates using its ESD platform, with a lead program (OraPro-EBV) targeting Epstein-Barr Virus. The company operates in the biotechnology and vaccine development sector.
Founders & leadership
WC
Wayne ChannonExecutive Chairman
EB
Elliot BlandCOO
CL
Craig LaferrièreCDO